Sameer Sachdeva

Title: Sameer Sachdeva: Innovator in Synthetic Antibody Mimic Peptides

Introduction

Sameer Sachdeva is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic antibody mimic peptides. His work focuses on creating peptide molecules that replicate the binding and functional properties of native antibodies.

Latest Patents

Sameer Sachdeva holds 1 patent for his innovative work on synthetic antibody mimic peptides. This patent encompasses compositions and methods that include peptide molecules designed to mimic the binding and functional properties of native antibodies. The targets of these mimic peptides include critical proteins such as epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), vascular endothelial growth factor (VEGF), programmed cell death protein 1 (PD-1), and programmed death-ligand 1 (PD-L1). His research also applies the knob-socket computational model to design these antibody mimics effectively.

Career Highlights

Sameer is currently associated with Formurex, Inc., where he continues to advance his research in synthetic peptides. His work has the potential to impact various therapeutic areas, particularly in cancer treatment and immunotherapy.

Collaborations

Sameer has collaborated with notable colleagues, including Xiaoling Li and Jerry Tsai, who contribute to the innovative environment at Formurex, Inc. Their combined expertise enhances the research and development of new therapeutic solutions.

Conclusion

Sameer Sachdeva is a pioneering inventor whose work in synthetic antibody mimic peptides is paving the way for advancements in biotechnology. His contributions are significant in the ongoing quest for effective therapeutic interventions.